AGIOS PHARMACEUTICALS, INC. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Schenkein David P | — | Option Exercise | 3,388 | — | — | 126,242 | Jun 13, 2024 |
| Ballal Rahul D. | — | Option Exercise | 3,388 | — | — | 5,690 | Jun 13, 2024 |
| Smith Cynthia | — | Option Exercise | 3,388 | — | — | 5,690 | Jun 13, 2024 |
| Ho Maykin | — | Option Exercise | 3,388 | — | — | 14,912 | Jun 13, 2024 |
| Scadden David | — | Option Exercise | 3,388 | — | — | 15,483 | Jun 13, 2024 |
| Owen Catherine E. | — | Option Exercise | 1,976 | — | — | 1,976 | Jun 13, 2024 |
| CAPELLO JEFFREY D | — | Option Exercise | 1,976 | — | — | 1,976 | Jun 13, 2024 |
| Goff Brian | Chief Executive Officer | Option Exercise | 25,527 | — | — | 79,307 | Jun 5, 2024 |
| Washburn Theodore James Jr. | Principal Accounting Officer | Sale | 1,362 | $44.39 | $60,459 | 1,524 | Jun 3, 2024 |
| FOUSE JACQUALYN A | — | Option Exercise | 15,934 | — | — | 145,187 | Apr 10, 2024 |
| Foster-Cheek Kaye I | — | Sale | 1,285 | $31.62 | $40,632 | 5,524 | Mar 7, 2024 |
| Foster-Cheek Kaye I | — | Sale | 4,415 | $31.99 | $141,236 | 6,809 | Mar 5, 2024 |
| Washburn Theodore James Jr. | Principal Accounting Officer | Sale | 1,913 | $31.75 | $60,738 | 2,886 | Mar 5, 2024 |
| Jones Cecilia | Chief Financial Officer | Option Exercise | 2,000 | — | — | 15,512 | Mar 5, 2024 |
| Goff Brian | Chief Executive Officer | Option Exercise | 8,500 | — | — | 57,936 | Mar 5, 2024 |
| Burns James William | Chief Legal Officer | Option Exercise | 4,000 | — | — | 38,518 | Mar 5, 2024 |
| Gheuens Sarah | Chief Medical Officer | Option Exercise | 4,000 | — | — | 40,415 | Mar 1, 2024 |
| Washburn Theodore James Jr. | Principal Accounting Officer | Sale | 919 | $32.57 | $29,932 | 4,799 | Mar 1, 2024 |
| Schenkein David P | — | Option Exercise | 57,471 | $31.64 | $1,818,382 | 180,325 | Feb 27, 2024 |
| Schenkein David P | — | Sale | 47,731 | $33.05 | $1,577,510 | 122,854 | Feb 26, 2024 |
| Washburn Theodore James Jr. | Principal Accounting Officer | Sale | 504 | $26.63 | $13,422 | 2,741 | Feb 20, 2024 |
| Burns James William | Chief Legal Officer | Option Exercise | 1,833 | — | — | 32,211 | Feb 14, 2024 |
| Gheuens Sarah | Chief Medical Officer | Sale | 642 | $25.14 | $16,140 | 33,431 | Feb 12, 2024 |
| Washburn Theodore James Jr. | Principal Accounting Officer | Sale | 273 | $25.14 | $6,863 | 3,245 | Feb 12, 2024 |
| Burns James William | Chief Legal Officer | Option Exercise | 5,750 | — | — | 32,086 | Jan 24, 2024 |
| Gheuens Sarah | Chief Medical Officer | Option Exercise | 5,750 | — | — | 33,619 | Jan 24, 2024 |
| Jones Cecilia | Chief Financial Officer | Option Exercise | 5,380 | — | — | 14,955 | Jan 24, 2024 |
| FOUSE JACQUALYN A | — | Sale | 10,722 | $21.64 | $232,024 | 129,253 | Jan 20, 2024 |
| Goff Brian | Chief Executive Officer | Sale | 7,635 | $21.64 | $165,221 | 49,436 | Jan 20, 2024 |
| Milanova Tsveta | Chief Commercial Officer | Sale | 1,618 | $21.64 | $35,014 | 13,234 | Jan 20, 2024 |
| Goff Brian | Chief Executive Officer | Option Exercise | 25,527 | — | — | 52,119 | Jan 9, 2024 |
| FOUSE JACQUALYN A | — | Option Exercise | 17,500 | — | — | 124,466 | Jan 9, 2024 |
| Burns James William | Chief Legal Officer | Option Exercise | 3,250 | — | — | 27,499 | Jan 9, 2024 |
| Gheuens Sarah | Chief Medical Officer | Option Exercise | 5,000 | — | — | 29,658 | Jan 9, 2024 |
| Milanova Tsveta | Chief Commercial Officer | Option Exercise | 8,475 | — | — | 12,306 | Jan 5, 2024 |
| Jones Cecilia | Chief Financial Officer | Sale | 2,179 | $24.79 | $54,017 | 9,575 | Sep 26, 2023 |
| Burns James William | Chief Legal Officer | Sale | 6,395 | $26.28 | $168,061 | 23,890 | Aug 17, 2023 |
| Ballal Rahul D. | — | Option Exercise | 2,302 | — | — | 2,302 | Aug 11, 2023 |
| Smith Cynthia | — | Option Exercise | 2,302 | — | — | 2,302 | Aug 11, 2023 |
| Foster-Cheek Kaye I | — | Sale | 25,000 | $25.96 | $649,000 | 11,524 | Aug 9, 2023 |
| Goff Brian | Chief Executive Officer | Option Exercise | 22,691 | — | — | 36,770 | Aug 8, 2023 |
| Washburn Theodore James Jr. | Principal Accounting Officer | Sale | 2,918 | $25.39 | $74,088 | 2,741 | Aug 7, 2023 |
| Washburn Theodore James Jr. | Principal Accounting Officer | Sale | 1,232 | $26.26 | $32,352 | 5,659 | Aug 1, 2023 |
| Burns James William | Chief Legal Officer | Option Exercise | 5,750 | — | — | 31,992 | Jun 30, 2023 |
| FOUSE JACQUALYN A | — | Option Exercise | 23,900 | — | — | 117,684 | Jun 30, 2023 |
| Gheuens Sarah | Chief Medical Officer | Option Exercise | 5,750 | — | — | 25,866 | Jun 30, 2023 |
| Jones Cecilia | Chief Financial Officer | Option Exercise | 5,380 | — | — | 5,380 | Jun 30, 2023 |
| Goff Brian | Chief Executive Officer | Sale | 11,449 | $28.36 | $324,694 | 14,079 | Jun 28, 2023 |
| Milanova Tsveta | Chief Commercial Officer | Sale | 1,618 | $28.36 | $45,886 | 3,831 | Jun 28, 2023 |
| Foster-Cheek Kaye I | — | Option Exercise | 4,975 | — | — | 11,524 | Jun 21, 2023 |